Search research articles
Contact Us
Filters
Showing results (831-840 of 862) with videos related to
Page
of 87
Sort By:
Hypertension (Dallas, Tex. : 1979)
|
December 28, 2017
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma
Britta Heinze, Carmina T Fuss, Paolo Mulatero, et al.
The Lancet. Oncology
|
August 29, 2017
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial
Hagop M Kantarjian, Gail J Roboz, Patricia L Kropf, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 15, 2013
Chronic Myelogenous Leukemia, Version 1.2014
Susan O'Brien, Jerald P Radich, Camille N Abboud, et al.
EMBO Molecular Medicine
|
March 5, 2015
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
Kathrin Philipp-Abbrederis, Ken Herrmann, Stefan Knop, et al.
ESC Heart Failure
|
July 15, 2022
Peak O<sub>2</sub> -pulse predicts exercise training-induced changes in peak V̇O<sub>2</sub> in heart failure with preserved ejection fraction
Stephan Mueller, Bernhard Haller, Anna Feuerstein, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 2, 2014
Chronic myelogenous leukemia, version 1.2015
Susan O'Brien, Jerald P Radich, Camille N Abboud, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 15, 2015
Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms
Brady L Stein, Jason Gotlib, Murat Arcasoy, et al.
Science Translational Medicine
|
December 6, 2023
Intervertebral disc human nucleus pulposus cells associated with back pain trigger neurite outgrowth in vitro and pain behaviors in rats
Wensen Jiang, Juliane D Glaeser, Giselle Kaneda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2022
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine
Casey L O'Connell, Maria R Baer, Andreas Due Ørskov, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2020
Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)Validation
Julie Farand, Jeffrey E Kropf, Peter Blomgren, et al.
Page
of 87
Search research articles
Search
Showing results (831-840 of 862) with videos related to
Sort By:
Page
of 87
Hypertension (Dallas, Tex. : 1979)
|
December 28, 2017
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma
Britta Heinze, Carmina T Fuss, Paolo Mulatero, et al.
The Lancet. Oncology
|
August 29, 2017
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial
Hagop M Kantarjian, Gail J Roboz, Patricia L Kropf, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 15, 2013
Chronic Myelogenous Leukemia, Version 1.2014
Susan O'Brien, Jerald P Radich, Camille N Abboud, et al.
EMBO Molecular Medicine
|
March 5, 2015
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
Kathrin Philipp-Abbrederis, Ken Herrmann, Stefan Knop, et al.
ESC Heart Failure
|
July 15, 2022
Peak O<sub>2</sub> -pulse predicts exercise training-induced changes in peak V̇O<sub>2</sub> in heart failure with preserved ejection fraction
Stephan Mueller, Bernhard Haller, Anna Feuerstein, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 2, 2014
Chronic myelogenous leukemia, version 1.2015
Susan O'Brien, Jerald P Radich, Camille N Abboud, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 15, 2015
Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms
Brady L Stein, Jason Gotlib, Murat Arcasoy, et al.
Science Translational Medicine
|
December 6, 2023
Intervertebral disc human nucleus pulposus cells associated with back pain trigger neurite outgrowth in vitro and pain behaviors in rats
Wensen Jiang, Juliane D Glaeser, Giselle Kaneda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2022
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine
Casey L O'Connell, Maria R Baer, Andreas Due Ørskov, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2020
Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)Validation
Julie Farand, Jeffrey E Kropf, Peter Blomgren, et al.
Page
of 87